Research Article 
Randomized trial of custom orthoses and footwear on foot pain and plantar pressure in diabetic peripheral arterial disease
J. Burns, C. Wegener, L. Begg, M. Vicaretti and J. Fletcher
Diabetic Medicine, 2009, 26(9), 893-899. DOI: 10.1111/j.1464-5491.2009.02799.x
Abstract
Aim Custom-made foot orthoses reduce plantar pressure, ulceration and amputation in patients with diabetes mellitus. There is limited evidence of their effect on foot pain. In a randomized, single-blind, sham-controlled trial, the efficacy of custom orthoses on foot pain and plantar pressure in diabetic patients with peripheral arterial disease was investigated.
Methods Sixty-one participants were randomly assigned to either custom foot orthoses (n = 30) or sham insoles (n = 31). Both groups also received standardized walking footwear. Outcomes included foot pain and function, mean pressure, toe-brachial index, average daily steps, disability, comfort, quality of life, adherence and adverse events. A multivariate predictive model was constructed to explore factors contributing to pain relief during the trial.
Results At 8 weeks, 95% of participants provided follow-up data, adherence was high and there were few adverse events. Foot pain and function scores significantly improved at 8 weeks with both custom orthoses and the sham, but there was no significant difference between groups. Custom orthoses reduced pressure significantly more than the sham. There were no significant differences between groups for toe-brachial index, daily steps, disability, comfort or quality of life. Regression modelling identified inappropriate pre-trial footwear as the strongest predictor of foot pain relief during the trial.
Conclusions Custom foot orthoses significantly reduced plantar pressure compared with the sham, but there were no significant differences between groups for pain or function. The high-quality walking footwear provided to both groups may explain this finding. Footwear should have greater emphasis as the clinical intervention.
ASCI-ID: 109-651
Similar Articles
The consequences of complacency: managing the effects of unrecognized Charcot feet
Diabetic Medicine, 2011, 28(2), 195-198. DOI: 10.1111/j.1464-5491.2010.03141.x
Measuring the accuracy of different ways to identify the ‘at-risk’ foot in routine clinical practiceDiabetic Medicine, 2011, 28(6), 747-754. DOI: 10.1111/j.1464-5491.2011.03297.x
Small-fibre involvement in diabetic patients with neuropathic foot painDiabetic Medicine, 2008, 25(6), 692-699. DOI: 10.1111/j.1464-5491.2008.02446.x
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trialDiabetic Medicine, 2009, 26(10), 1019-1026. DOI: 10.1111/j.1464-5491.2009.02806.x
Exercise treadmill testing in patients with claudication, with and without diabetesDiabetic Medicine, 2011, 28(3), 356-362. DOI: 10.1111/j.1464-5491.2010.03208.x
Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetesDiabetic Medicine, 2010, 27(5), 578-584. DOI: 10.1111/j.1464-5491.2010.02971.x
Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetesDiabetic Medicine, 2007, 24(6), 607-617. DOI: 10.1111/j.1464-5491.2007.02120.x
Health utility values associated with diabetic retinopathyDiabetic Medicine, 2008, 25(5), 618-624. DOI: 10.1111/j.1464-5491.2008.02430.x
Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus—a large-scale multicentre pilot study1Diabetic Medicine, 2009, 26(5), 493-501. DOI: 10.1111/j.1464-5491.2009.02707.x
Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic reviewDiabetic Medicine, 2010, 27(7), 812-822. DOI: 10.1111/j.1464-5491.2010.03029.x
Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary careDiabetic Medicine, 2011, 28(9), 1096-1102. DOI: 10.1111/j.1464-5491.2011.03329.x
Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injectionsDiabetic Medicine, 2008, 25(2), 213-220. DOI: 10.1111/j.1464-5491.2007.02346.x
Quality of life in children with Type 1 diabetes: a comparison of general and diabetes-specific measures and support for a unitary diabetes quality-of-life constructDiabetic Medicine, 2008, 25(11), 1316-1323. DOI: 10.1111/j.1464-5491.2008.02574.x
Not all roads lead to Rome-a review of quality of life measurement in adults with diabetesDiabetic Medicine, 2009, 26(4), 315-327. DOI: 10.1111/j.1464-5491.2009.02682.x
Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetesDiabetic Medicine, 2010, 27(5), 578-584. DOI: 10.1111/j.1464-5491.2010.02971.x
People living with diabetes resident in nursing homes-assessing levels of disability and nursing needsDiabetic Medicine, 2011, 28(7), 778-780. DOI: 10.1111/j.1464-5491.2011.03261.x
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative reviewDiabetic Medicine, 2012, 29(3), 293-302. DOI: 10.1111/j.1464-5491.2011.03416.x
Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studiesDiabetic Medicine, 2012, 29(4), 515-521. DOI: 10.1111/j.1464-5491.2011.03436.x
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetesDiabetic Medicine, 2012, 29(6), 716-720. DOI: 10.1111/j.1464-5491.2011.03547.x